Regeneron Pharmaceuticals, Inc.

Biotechnology & Medical Research

Company Summary

Regeneron Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceuticals to treat a variety of medical problems around the world. Regeneron Pharmaceuticals, Inc. is based in Tarrytown, New York, and was formed in 1988.

ESG Rating Overview

Sustainalytics

Overall ESG Rating :

21
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
0100E0S13.2G7.3

Refinitiv

Overall ESG Rating :

63
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
0100E58S97G36

Overall ESG Rating :

BBB
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader

Regeneron is average among 41 companies in the biotechnology industry.

Temperature Rise :

1.59℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned